Researcher.Life Logo

International Journal of Hematology : Impact Factor & More

eISSN: 1865-3774pISSN: 0925-5710

Aims and Scope of International Journal of Hematology

International Journal of Hematology is the official journal of the Japanese Society of Hematology. Since 2008, it has been published by Springer Japan, but used to be published by Carden Jennings.

Key Metrics

CiteScore
3.9
Impact Factor
< 5
SJR
Q2Hematology
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Journal of Hematology

International Journal of Hematology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGER JAPAN KK
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in International Journal of Hematology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Journal of Hematology

Effectiveness and tolerability of switching from 20% subcutaneous immunoglobulin to hyaluronidase-facilitated subcutaneous immunoglobulin 10% in the same patients with secondary hypogammaglobulinemia.
  • 20 May 2026
  • International journal of hematology
Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan.
  • 18 May 2026
  • International journal of hematology
Daratumumab-based therapy in systemic AL amyloidosis including advanced cardiac involvement: a single center study.
  • 18 May 2026
  • International journal of hematology
Letter comments on: "Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan".
  • 13 May 2026
  • International journal of hematology
T-cell fitness, metabolic tumor volume, and serum LDH levels are associated with response to axicabtagene ciloleucel.
  • 12 May 2026
  • International journal of hematology
Personalized multivariable clinical prognostic model for patients with acute myeloid leukemia receiving intensive chemotherapy.
  • 12 May 2026
  • International journal of hematology
Effectiveness and tolerability of switching from 20% subcutaneous immunoglobulin to hyaluronidase-facilitated subcutaneous immunoglobulin 10% in the same patients with secondary hypogammaglobulinemia.
  • 20 May 2026
  • International journal of hematology
Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan.
  • 18 May 2026
  • International journal of hematology
Daratumumab-based therapy in systemic AL amyloidosis including advanced cardiac involvement: a single center study.
  • 18 May 2026
  • International journal of hematology
Letter comments on: "Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan".
  • 13 May 2026
  • International journal of hematology
T-cell fitness, metabolic tumor volume, and serum LDH levels are associated with response to axicabtagene ciloleucel.
  • 12 May 2026
  • International journal of hematology
Personalized multivariable clinical prognostic model for patients with acute myeloid leukemia receiving intensive chemotherapy.
  • 12 May 2026
  • International journal of hematology

FAQs on International Journal of Hematology